Assignee
60 DEGREES PHARMACEUTICALS LLC
US·9 granted patents·7 pending applications·21 citations·filing 2014–2024
Top patents by PatentIndex Score
16 records- 0188US11633391B2Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2021·Granted Apr 25, 2023·2 cites·47 claims
- 0286US10342791B2Regimens of tafenoquine for prevention of malaria in malaria-naive subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2015·Granted Jul 9, 2019·9 cites·31 claims
- 0385US10888558B2Regimens of tafenoquine for prevention of malaria in malaria-naive subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2019·Granted Jan 12, 2021·3 cites·33 claims
- 0483US11744828B2Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2021·Granted Sep 5, 2023·1 cites·10 claims
- 0579US10517854B2Dosing regiments of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2017·Granted Dec 31, 2019·3 cites·20 claims
- 0677US2024082233A1Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0775US9763921B2Dosing regimens of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2014·Granted Sep 19, 2017·3 cites·66 claims
- 0874US2024390359A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0974US2025073222A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1069US2024408074A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof of60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1167US12383546B2Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2022·Granted Aug 12, 2025·0 cites·22 claims
- 1264US2024226087A9Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1363US11219616B2Dosing regimens of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2019·Granted Jan 11, 2022·0 cites·13 claims
- 1461US2024165099A1Methods for the treatment and prevention of diseases or infections with mcp-1 involvement by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1553US2022387419A1Methods for the treatment and prevention of lung infections caused by sars-cov-2 virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1633US11000516B2Dosing regimens of celgosivir for the prevention of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2016·Granted May 11, 2021·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when 60 DEGREES PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →